Moody Aldrich Partners LLC Repligen Corp Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

A detailed history of Moody Aldrich Partners LLC transactions in Repligen Corp stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 1,505 shares of RGEN stock, worth $219,398. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,505
Holding current value
$219,398
% of portfolio
0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$119.79 - $167.35 $180,283 - $251,861
1,505 New
1,505 $223,000
Q1 2024

Apr 29, 2024
SELL
$170.78 - $208.42 $1,024 - $1,250
-6 Reduced 0.5%
1,186 $218,000
Q4 2023

Jan 25, 2024
BUY
$114.17 - $185.35 $136,090 - $220,937
1,192 New
1,192 $214,000
Q1 2023

Apr 27, 2023
SELL
$154.26 - $198.1 $462 - $594
-3 Reduced 0.23%
1,286 $216,000
Q4 2022

Jan 23, 2023
SELL
$162.42 - $220.56 $2,273 - $3,087
-14 Reduced 1.07%
1,289 $0
Q3 2022

Oct 18, 2022
SELL
$160.42 - $256.21 $4.92 Million - $7.85 Million
-30,645 Reduced 95.92%
1,303 $244,000
Q2 2022

Jul 18, 2022
BUY
$140.68 - $188.02 $4.02 Million - $5.38 Million
28,605 Added 855.67%
31,948 $5.19 Million
Q1 2022

May 10, 2022
BUY
$161.19 - $257.96 $211,803 - $338,959
1,314 Added 64.76%
3,343 $629,000
Q4 2021

Feb 02, 2022
SELL
$247.59 - $304.47 $6,684 - $8,220
-27 Reduced 1.31%
2,029 $537,000
Q3 2021

Oct 29, 2021
SELL
$194.77 - $324.21 $194 - $324
-1 Reduced 0.05%
2,056 $594,000
Q2 2021

Aug 04, 2021
SELL
$165.87 - $220.95 $4,976 - $6,628
-30 Reduced 1.44%
2,057 $411,000
Q1 2021

May 10, 2021
BUY
$180.37 - $226.26 $60,965 - $76,475
338 Added 19.33%
2,087 $406,000
Q4 2020

Feb 16, 2021
SELL
$148.08 - $206.57 $1,776 - $2,478
-12 Reduced 0.68%
1,749 $335,000
Q3 2020

Nov 12, 2020
SELL
$122.51 - $158.27 $59,662 - $77,077
-487 Reduced 21.66%
1,761 $260,000
Q2 2020

Jul 30, 2020
SELL
$94.33 - $140.48 $4.46 Million - $6.64 Million
-47,268 Reduced 95.46%
2,248 $278,000
Q1 2020

May 07, 2020
BUY
$84.96 - $109.14 $93,625 - $120,272
1,102 Added 2.28%
49,516 $4.78 Million
Q4 2019

Feb 07, 2020
BUY
$73.84 - $93.08 $423,989 - $534,465
5,742 Added 13.46%
48,414 $4.48 Million
Q3 2019

Nov 12, 2019
BUY
$76.65 - $95.51 $3.27 Million - $4.08 Million
42,672 New
42,672 $3.27 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email